Skip to main content
Erschienen in:

19.08.2022 | Original Paper

Comparison of the efficacy of gossypol acetate enantiomers in rats with uterine leiomyoma

verfasst von: Jie Yuan, Mengyu Zhou, Xiaobing Xin, Jun Yao, Junmin Chang

Erschienen in: Journal of Natural Medicines | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Gossypol acetate (GA), as the product of racemic gossypol and acetic acid conjugated by hydrogen bond, is hydrolyzed into gossypol to exert its effect on treating uterine leiomyoma (UL), which has been listed in China. But hypokalemia and mild changes of liver function limit its clinical application. It had been reported that the biological activities of gossypol optical isomers were different. In this study, we aimed to clarify whether there were differences in the efficacy of gossypol enantiomers and whether a single gossypol optical isomer could alleviate adverse reactions in the treatment of UL. The results indicated that (−)-GA and (+)-GA had significant therapeutic effect on rats with UL. Interestingly, (−)-GA could better significantly ameliorate the pathological structure, inhibit the secretion of estrogen, and downregulate the expression of estrogen receptor-alpha (ER-α) and progesterone receptor (PR) than (+)-GA. Additionally, (−)-GA could better evidently decrease the symptoms of abnormally elevated inflammatory factors caused by UL. In contrast, (−)-GA and (+)-GA had certain effects on potassium ion concentration in serum, liver and kidney function, and the effects of (+)-GA on liver function were more obvious than (−)-GA. These findings will be of great significance to the drug development of gossypol optical isomers.

Graphical abstract

Literatur
1.
Zurück zum Zitat Krempl C, Sporer T, Reichelt M, Ahn SJ, Heidel-Fischer H, Vogel H, Heckel DG, Joußen N (2016) Potential detoxification of gossypol by UDP-glycosyltransferases in the two Heliothine moth species Helicoverpa armigera and Heliothis virescens. Insect Biochem Molec 71:49–57CrossRef Krempl C, Sporer T, Reichelt M, Ahn SJ, Heidel-Fischer H, Vogel H, Heckel DG, Joußen N (2016) Potential detoxification of gossypol by UDP-glycosyltransferases in the two Heliothine moth species Helicoverpa armigera and Heliothis virescens. Insect Biochem Molec 71:49–57CrossRef
2.
Zurück zum Zitat Liu SL, Kulp SK, Sugimoto Y, Jiang JH, Chang HL, Dowd MK, Wan P, Lin YC (2002) The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer. Anticancer Res 22:33–38 Liu SL, Kulp SK, Sugimoto Y, Jiang JH, Chang HL, Dowd MK, Wan P, Lin YC (2002) The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer. Anticancer Res 22:33–38
3.
Zurück zum Zitat Chen CW, Hu S, Tsui KH, Hwang GS, Chen ST, Tang TK, Cheng HT, Yu JW, Wang HC, Juang HH, Wang PS, Wang SW (2018) Anti-inflammatory effects of gossypol on human lymphocytic jurkat cells via regulation of MAPK signaling and cell cycle. Inflammation 41:2265–2274CrossRef Chen CW, Hu S, Tsui KH, Hwang GS, Chen ST, Tang TK, Cheng HT, Yu JW, Wang HC, Juang HH, Wang PS, Wang SW (2018) Anti-inflammatory effects of gossypol on human lymphocytic jurkat cells via regulation of MAPK signaling and cell cycle. Inflammation 41:2265–2274CrossRef
4.
Zurück zum Zitat Liu ZC, Yang ZT, Fu YH, Li FY, Liang DJ, Zhou ES, Song XJ, Zhang W, Zhang XC, Cao YG, Zhang NS (2013) Protective effect of gossypol on lipopolysaccharide-induced acute lung injury in mice. Inflamm Res 62:499–506CrossRef Liu ZC, Yang ZT, Fu YH, Li FY, Liang DJ, Zhou ES, Song XJ, Zhang W, Zhang XC, Cao YG, Zhang NS (2013) Protective effect of gossypol on lipopolysaccharide-induced acute lung injury in mice. Inflamm Res 62:499–506CrossRef
5.
Zurück zum Zitat Kaushal NA, Kaushal DC (2014) Production and characterization of monoclonal antibodies against substrate specific loop region of Plasmodium falciparum lactate dehydrogenase. Immunol Invest 43:556–571CrossRef Kaushal NA, Kaushal DC (2014) Production and characterization of monoclonal antibodies against substrate specific loop region of Plasmodium falciparum lactate dehydrogenase. Immunol Invest 43:556–571CrossRef
6.
Zurück zum Zitat Gao YN, Tai WB, Wang N, Li X, Jiang SB, Debnath AK, Du LY, Chen SZ (2019) Identification of novel natural products as effective and broad-spectrum anti-zika virus inhibitors. Viruses 11:1019–1036CrossRef Gao YN, Tai WB, Wang N, Li X, Jiang SB, Debnath AK, Du LY, Chen SZ (2019) Identification of novel natural products as effective and broad-spectrum anti-zika virus inhibitors. Viruses 11:1019–1036CrossRef
7.
Zurück zum Zitat Li L, Li Z, Wang KL, Liu YX, Li YQ, Wang QM (2016) Synthesis and antiviral, insecticidal, and fungicidal activities of gossypol derivatives containing alkylimine, oxime or hydrazine moiety. Bioorgan Med Chem 24:474–483CrossRef Li L, Li Z, Wang KL, Liu YX, Li YQ, Wang QM (2016) Synthesis and antiviral, insecticidal, and fungicidal activities of gossypol derivatives containing alkylimine, oxime or hydrazine moiety. Bioorgan Med Chem 24:474–483CrossRef
8.
Zurück zum Zitat Ei-Sharaky AS, Newairy AA, Elguindy NM, Elwafa AA (2010) Spermatotoxicity, biochemical changes and histological alteration induced by gossypol in testicular and hepatic tissues of male rats. Food Chem Toxicol 48:3354–3361CrossRef Ei-Sharaky AS, Newairy AA, Elguindy NM, Elwafa AA (2010) Spermatotoxicity, biochemical changes and histological alteration induced by gossypol in testicular and hepatic tissues of male rats. Food Chem Toxicol 48:3354–3361CrossRef
9.
Zurück zum Zitat Liu YQ, Ma YL, Li Z, Yang Y, Yu B, Zhang ZY, Wang GY (2020) Investigation of inhibition effect of gossypol-acetic acid on gastric cancer cells based on a network pharmacology approach and experimental validation. Drug Des Dev Ther 14:3615–3623CrossRef Liu YQ, Ma YL, Li Z, Yang Y, Yu B, Zhang ZY, Wang GY (2020) Investigation of inhibition effect of gossypol-acetic acid on gastric cancer cells based on a network pharmacology approach and experimental validation. Drug Des Dev Ther 14:3615–3623CrossRef
10.
Zurück zum Zitat Beyazit N, Çakran HS, Cabir A, Akışcan Y, Demetgül C (2020) Synthesis, characterization and antioxidant activity of chitosan Schiff base derivatives bearing (-)-gossypol. Carbohyd Polym 240:116333–116341CrossRef Beyazit N, Çakran HS, Cabir A, Akışcan Y, Demetgül C (2020) Synthesis, characterization and antioxidant activity of chitosan Schiff base derivatives bearing (-)-gossypol. Carbohyd Polym 240:116333–116341CrossRef
11.
Zurück zum Zitat Kovacic P (2003) Mechanism of drug and toxic actions of gossypol: focus on reactive oxygen species and electron transfer. Curr Med Chem 10:2711–2718CrossRef Kovacic P (2003) Mechanism of drug and toxic actions of gossypol: focus on reactive oxygen species and electron transfer. Curr Med Chem 10:2711–2718CrossRef
12.
Zurück zum Zitat Wang XF, Li XQ, Leng XJ, Shan LL, Zhao JX, Wang YT (2014) Effects of dietary cottonseed meal level on the growth, hematological indices, liver and gonad histology of juvenile common carp (Cyprinus carpio). Aquaculture 428:79–87CrossRef Wang XF, Li XQ, Leng XJ, Shan LL, Zhao JX, Wang YT (2014) Effects of dietary cottonseed meal level on the growth, hematological indices, liver and gonad histology of juvenile common carp (Cyprinus carpio). Aquaculture 428:79–87CrossRef
13.
Zurück zum Zitat Santana AT, Guelfi M, Medeiros HCD, Tavares MA, Bizerra PFV (2015) Mechanisms involved in reproductive damage caused by gossypol in rats and protective effects of vitamin E. Biol Res 48:43–50CrossRef Santana AT, Guelfi M, Medeiros HCD, Tavares MA, Bizerra PFV (2015) Mechanisms involved in reproductive damage caused by gossypol in rats and protective effects of vitamin E. Biol Res 48:43–50CrossRef
14.
Zurück zum Zitat EI Sabeh M, Saha SK, Afrin S, Islam MS, Borahay MA (2021) Wnt/β-catenin signaling pathway in uterine leiomyoma: role in tumor biology and targeting opportunities. Mol Cell Biochem 476:3513–3536CrossRef EI Sabeh M, Saha SK, Afrin S, Islam MS, Borahay MA (2021) Wnt/β-catenin signaling pathway in uterine leiomyoma: role in tumor biology and targeting opportunities. Mol Cell Biochem 476:3513–3536CrossRef
15.
Zurück zum Zitat Geethamala K, Murthy VS, Vani BR, Rao S (2016) Uterine leiomyomas: an enigma. J Midlife Health 7:22–27 Geethamala K, Murthy VS, Vani BR, Rao S (2016) Uterine leiomyomas: an enigma. J Midlife Health 7:22–27
16.
Zurück zum Zitat Chegini N, Verala J, Luo X, Xu J, Williams RS (2003) Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Invest 10:161–171CrossRef Chegini N, Verala J, Luo X, Xu J, Williams RS (2003) Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Invest 10:161–171CrossRef
17.
Zurück zum Zitat Mallick DJ, Eastman A (2020) AT101 [(-)-Gossypol] selectively inhibits MCL1 and sensitizes carcinoma to BH3 mimetics by inducing and stabilizing NOXA. Cancers 12:2298–2313CrossRef Mallick DJ, Eastman A (2020) AT101 [(-)-Gossypol] selectively inhibits MCL1 and sensitizes carcinoma to BH3 mimetics by inducing and stabilizing NOXA. Cancers 12:2298–2313CrossRef
18.
Zurück zum Zitat Chen Y, Sten M, Nordenskjöld M, Lambert B, Matlin SA, Zhou RH (1986) The effect of gossypol on the frequency of DNA-strand breaks in human leukocytes in vitro. Mutat Res 164:71–78CrossRef Chen Y, Sten M, Nordenskjöld M, Lambert B, Matlin SA, Zhou RH (1986) The effect of gossypol on the frequency of DNA-strand breaks in human leukocytes in vitro. Mutat Res 164:71–78CrossRef
19.
Zurück zum Zitat Vela L, Marzo I (2015) Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside. Curr Opin Pharmacol 23:74–81CrossRef Vela L, Marzo I (2015) Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside. Curr Opin Pharmacol 23:74–81CrossRef
20.
Zurück zum Zitat Wang GP, Nikolovska-Coleska Z, Yang CY, Wang RX, Tang GZ, Guo J, Shangary S, Qiu S, Gao W, Yang DJ, Meagher J, Stuckey J, Krajewski K, Jiang S, Roller PP, Abaan HO, Tomita Y, Wang SM (2006) Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. J Med Chem 49:6139–6142CrossRef Wang GP, Nikolovska-Coleska Z, Yang CY, Wang RX, Tang GZ, Guo J, Shangary S, Qiu S, Gao W, Yang DJ, Meagher J, Stuckey J, Krajewski K, Jiang S, Roller PP, Abaan HO, Tomita Y, Wang SM (2006) Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. J Med Chem 49:6139–6142CrossRef
21.
Zurück zum Zitat Opydo-Chanek M, Gonzalo O, Marzo I (2017) Multifaceted anticancer activity of BH3 mimetics: current evidence and future prospects. Biochem Pharmacol 136:12–23CrossRef Opydo-Chanek M, Gonzalo O, Marzo I (2017) Multifaceted anticancer activity of BH3 mimetics: current evidence and future prospects. Biochem Pharmacol 136:12–23CrossRef
22.
Zurück zum Zitat Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26:1324–1337CrossRef Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26:1324–1337CrossRef
23.
Zurück zum Zitat Keshmiri-Neghab H, Goliaei B (2014) Therapeutic potential of gossypol: an overview. Pharm Biol 52:124–128CrossRef Keshmiri-Neghab H, Goliaei B (2014) Therapeutic potential of gossypol: an overview. Pharm Biol 52:124–128CrossRef
24.
Zurück zum Zitat Heist RS, Fain J, Chinnasami B, Khan W, Molina JR, Sequist LV, Temel JS, Fidias P, Brainerd V, Leopold L, Lynch TJ (2010) Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer. J Thorac Oncol 5:1637–1643CrossRef Heist RS, Fain J, Chinnasami B, Khan W, Molina JR, Sequist LV, Temel JS, Fidias P, Brainerd V, Leopold L, Lynch TJ (2010) Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer. J Thorac Oncol 5:1637–1643CrossRef
25.
Zurück zum Zitat Baggstrom MQ, Qi YW, Koczywas M, Argiris A, Johnson EA, Millward MJ, Murphy SC, Erlichman C, Rudin CM, Govindan R (2011) A phase II study of AT-101 (gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer. J Thorac Oncol 6:1757–1760CrossRef Baggstrom MQ, Qi YW, Koczywas M, Argiris A, Johnson EA, Millward MJ, Murphy SC, Erlichman C, Rudin CM, Govindan R (2011) A phase II study of AT-101 (gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer. J Thorac Oncol 6:1757–1760CrossRef
26.
Zurück zum Zitat Stein MN, Goodin S, Gounder M, Gibbon D, Moss R, Portal D, Lindquist D, Zhao Y, Takebe N, Tan A, Aisner J, Lin H, Ready N, Mehnert JM (2019) A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors. Invest New Drug 38:855–865CrossRef Stein MN, Goodin S, Gounder M, Gibbon D, Moss R, Portal D, Lindquist D, Zhao Y, Takebe N, Tan A, Aisner J, Lin H, Ready N, Mehnert JM (2019) A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors. Invest New Drug 38:855–865CrossRef
27.
Zurück zum Zitat Swiecicki PL, Bellile E, Sacco AG, Pearson AT, Taylor JG, Jackson TL, Chepeha DB, Spector ME, Shuman A, Malloy K, Moyer J, McKean E, McLean S, Sukari A, Wolf GT, Eisbruch A, Prince M, Bradford C, Carey TE, Wang SM, Nör JE, Worden FP (2016) A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer. Invest New Drug 34:481–489CrossRef Swiecicki PL, Bellile E, Sacco AG, Pearson AT, Taylor JG, Jackson TL, Chepeha DB, Spector ME, Shuman A, Malloy K, Moyer J, McKean E, McLean S, Sukari A, Wolf GT, Eisbruch A, Prince M, Bradford C, Carey TE, Wang SM, Nör JE, Worden FP (2016) A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer. Invest New Drug 34:481–489CrossRef
28.
Zurück zum Zitat MacVicar GR, Kuzel TM, Curti BD, Poiesz B, Somer BG, Greco FA, Gressler V, Brill K, Leopold L (2008) An open-label, multicenter, phase I/II study of AT-101 in combination with docetaxel (D) and prednisone (P) in men with hormone refractory prostate cancer (HRPC). J Clin Oncol 26:16043–16043CrossRef MacVicar GR, Kuzel TM, Curti BD, Poiesz B, Somer BG, Greco FA, Gressler V, Brill K, Leopold L (2008) An open-label, multicenter, phase I/II study of AT-101 in combination with docetaxel (D) and prednisone (P) in men with hormone refractory prostate cancer (HRPC). J Clin Oncol 26:16043–16043CrossRef
29.
Zurück zum Zitat Liu G, Kelly WK, Wilding G, Leopold L, Brill K, Somer B (2009) An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer. Clin Cancer Res 15:3172–3176CrossRef Liu G, Kelly WK, Wilding G, Leopold L, Brill K, Somer B (2009) An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer. Clin Cancer Res 15:3172–3176CrossRef
30.
Zurück zum Zitat Sonpavde G, Matveev V, Burke JM, Caton JR, Fleming MT, Hutson TE, Galsky MD, Berry WR, Karlov P, Holmlund JT, Wood BA, Brookes M, Leopold L (2012) Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer. Ann Oncol 23:1803–1808CrossRef Sonpavde G, Matveev V, Burke JM, Caton JR, Fleming MT, Hutson TE, Galsky MD, Berry WR, Karlov P, Holmlund JT, Wood BA, Brookes M, Leopold L (2012) Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer. Ann Oncol 23:1803–1808CrossRef
31.
Zurück zum Zitat Masuelli L, Benvenuto M, Izzi V, Zago E, Mattera R, Cerbelli B, Potenza V, Fazi S, Ciuffa S, Tresoldi I, Lucarelli E, Modesti A, Bei R (2020) In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101. Invest New Drug 38:675–689CrossRef Masuelli L, Benvenuto M, Izzi V, Zago E, Mattera R, Cerbelli B, Potenza V, Fazi S, Ciuffa S, Tresoldi I, Lucarelli E, Modesti A, Bei R (2020) In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101. Invest New Drug 38:675–689CrossRef
32.
Zurück zum Zitat Mehner M, Kubelt C, Adamski V, Schmitt C, Synowitz M, Held-Feindt J (2020) Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells. J Cancer Res Clin Oncol 146:117–126CrossRef Mehner M, Kubelt C, Adamski V, Schmitt C, Synowitz M, Held-Feindt J (2020) Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells. J Cancer Res Clin Oncol 146:117–126CrossRef
33.
Zurück zum Zitat Yao J, Li HF, He XW, Li L, Lu Y (2014) Determination of gossypol isomer in compound acetic acid gossypol tablets by HPLC. Chin J Pharm Anal 34:1732–1736 Yao J, Li HF, He XW, Li L, Lu Y (2014) Determination of gossypol isomer in compound acetic acid gossypol tablets by HPLC. Chin J Pharm Anal 34:1732–1736
34.
Zurück zum Zitat Zhou MY, Gulisitan A, Li Y, Yao J (2020) Preparation and content determination of gossypol acetate optical isomer. J Xinjiang Med Univ 43:21–24 Zhou MY, Gulisitan A, Li Y, Yao J (2020) Preparation and content determination of gossypol acetate optical isomer. J Xinjiang Med Univ 43:21–24
35.
Zurück zum Zitat Luo N, Guan QY, Zheng LH, Qu XY, Dai H, Cheng ZP (2014) Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation. Transl Res 163:232–241CrossRef Luo N, Guan QY, Zheng LH, Qu XY, Dai H, Cheng ZP (2014) Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation. Transl Res 163:232–241CrossRef
37.
Zurück zum Zitat Shan M, Carlson KE, Bujotzek A, Wellner A, Gust R, Weber M, Katzenellenbogen JA, Haag R (2013) Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor. ACS Chem Biol 8:707–715CrossRef Shan M, Carlson KE, Bujotzek A, Wellner A, Gust R, Weber M, Katzenellenbogen JA, Haag R (2013) Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor. ACS Chem Biol 8:707–715CrossRef
38.
Zurück zum Zitat Benassayag C, Leroy MJ, Rigourd V, Robert B, Honoré JC, Mignot TM, Vacher-Lavenu MC, Chapron C, Ferré F (1999) Estrogen receptors (ERalpha/ERbeta) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma. Am J Physiol 276:1112–1118 Benassayag C, Leroy MJ, Rigourd V, Robert B, Honoré JC, Mignot TM, Vacher-Lavenu MC, Chapron C, Ferré F (1999) Estrogen receptors (ERalpha/ERbeta) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma. Am J Physiol 276:1112–1118
39.
Zurück zum Zitat Couse JF, Lindzey J, Grandien K, Gustafsson JÅ, Korach KS (1997) Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse. Endocrinology 138:4613–4621CrossRef Couse JF, Lindzey J, Grandien K, Gustafsson JÅ, Korach KS (1997) Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse. Endocrinology 138:4613–4621CrossRef
40.
Zurück zum Zitat Kim JJ, Kurita T, Bulun SE (2013) Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev 34:130–162CrossRef Kim JJ, Kurita T, Bulun SE (2013) Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev 34:130–162CrossRef
41.
Zurück zum Zitat Bodner K, Bodner-adler B, Kimberger O, Czerwenka K, Mayerhofer K (2004) Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors. Fertil Steril 81:1062–1066CrossRef Bodner K, Bodner-adler B, Kimberger O, Czerwenka K, Mayerhofer K (2004) Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors. Fertil Steril 81:1062–1066CrossRef
42.
Zurück zum Zitat Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, Creatsas G, Meligova AK, Alexis MN, Zoumpourlis V (2008) Estrogen receptor α and β in uterine fibroids: a basis for altered estrogen responsiveness. Fertil Steril 90:1878–1885CrossRef Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, Creatsas G, Meligova AK, Alexis MN, Zoumpourlis V (2008) Estrogen receptor α and β in uterine fibroids: a basis for altered estrogen responsiveness. Fertil Steril 90:1878–1885CrossRef
43.
Zurück zum Zitat Kim EH, Kim JY, Lee YH, Chong GO, Park JY, Hong DG (2014) Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and-resistant uterine fibroids. Obstet Gynecol Sci 57:144–150CrossRef Kim EH, Kim JY, Lee YH, Chong GO, Park JY, Hong DG (2014) Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and-resistant uterine fibroids. Obstet Gynecol Sci 57:144–150CrossRef
44.
Zurück zum Zitat Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1–20CrossRef Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1–20CrossRef
45.
Zurück zum Zitat Akira S, Hirano T, Taga T, Kishimoto T (1990) Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 4:2860–2867CrossRef Akira S, Hirano T, Taga T, Kishimoto T (1990) Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 4:2860–2867CrossRef
46.
Zurück zum Zitat Gagat M, Zielińska W, Mikołajczyk K, Zabrzyński J, Krajewski A, Klimaszewska-Wiśniewska A, Grzanka D, Grzanka A (2021) CRISPR-based activation of endogenous expression of TPM1 inhibits inflammatory response of primary human coronary artery endothelial and smooth muscle cells induced by recombinant human tumor necrosis factor α. Front Cell Dev Biol 9:668032–668055CrossRef Gagat M, Zielińska W, Mikołajczyk K, Zabrzyński J, Krajewski A, Klimaszewska-Wiśniewska A, Grzanka D, Grzanka A (2021) CRISPR-based activation of endogenous expression of TPM1 inhibits inflammatory response of primary human coronary artery endothelial and smooth muscle cells induced by recombinant human tumor necrosis factor α. Front Cell Dev Biol 9:668032–668055CrossRef
47.
Zurück zum Zitat Borthakur A, Prabhu YD, Gopalakrishnan AV (2020) Role of IL-6 signalling in polycystic ovarian syndrome associated inflammation. J Reprod Immunol 141:103155–103162CrossRef Borthakur A, Prabhu YD, Gopalakrishnan AV (2020) Role of IL-6 signalling in polycystic ovarian syndrome associated inflammation. J Reprod Immunol 141:103155–103162CrossRef
48.
Zurück zum Zitat Liu LX, Li QQ, Yang YJ, Guo AW (2021) Biological function of short-chain fatty acids and its regulation on intestinal health of poultry. Front Vet Sci 8:736739–736751CrossRef Liu LX, Li QQ, Yang YJ, Guo AW (2021) Biological function of short-chain fatty acids and its regulation on intestinal health of poultry. Front Vet Sci 8:736739–736751CrossRef
49.
Zurück zum Zitat Peng H, Harvey BT, Richards CI, Nixon K (2021) Neuron-derived extracellular vesicles modulate microglia activation and function. Biology 10:948–960CrossRef Peng H, Harvey BT, Richards CI, Nixon K (2021) Neuron-derived extracellular vesicles modulate microglia activation and function. Biology 10:948–960CrossRef
50.
Zurück zum Zitat Sang GW, Lorenzo B, Reidenberg MM (1991) Inhibitory effects of gossypol on corticosteroid 11-beta-hydroxysteroid dehydrogenase from guinea pig kidney: a possible mechanism for causing hypokalemia. J Steroid biochem molec biol 39:169–176CrossRef Sang GW, Lorenzo B, Reidenberg MM (1991) Inhibitory effects of gossypol on corticosteroid 11-beta-hydroxysteroid dehydrogenase from guinea pig kidney: a possible mechanism for causing hypokalemia. J Steroid biochem molec biol 39:169–176CrossRef
51.
Zurück zum Zitat Li XX, Du FY, Liu HX, Ji JB, Xing J (2015) Investigation of the active components in Tripterygium wilfordii leading to its acute hepatotoxicty and nephrotoxicity. J Ethnopharmacol 162:238–243CrossRef Li XX, Du FY, Liu HX, Ji JB, Xing J (2015) Investigation of the active components in Tripterygium wilfordii leading to its acute hepatotoxicty and nephrotoxicity. J Ethnopharmacol 162:238–243CrossRef
Metadaten
Titel
Comparison of the efficacy of gossypol acetate enantiomers in rats with uterine leiomyoma
verfasst von
Jie Yuan
Mengyu Zhou
Xiaobing Xin
Jun Yao
Junmin Chang
Publikationsdatum
19.08.2022
Verlag
Springer Nature Singapore
Erschienen in
Journal of Natural Medicines / Ausgabe 1/2023
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-022-01644-z